P1451L (p.Pro1451Leu) variant of SCN1A (Nav1.1)
P1451L (p.Pro1451Leu) in SCN1A (Nav1.1) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic/likely pathogenic in the context of Early-infantile DEE; Severe myoclonic epilepsy in infancy; See cases. The available variant effect predictions contribute to a CATVariant prioritization score of 0.87 / 1. The record also includes population frequency data, published literature, and structural context.
P1451L (p.Pro1451Leu) variant details
- p.Pro1451Leu
- rs121917945
- ClinGen CA284961
- ClinVar RCV000059418
- ClinVar RCV003224861
- Pathogenic/Likely pathogenic
- Early-infantile DEE; Severe myoclonic epilepsy in infancy; See cases
- Missense
- Variant Prioritization Score for Impact Estimate 0.871
- AlphaMissense 0.99
- MetaLR 0.98
- MetaSVM 1.01
- CADD 32.00
- PolyPhen-2 1.00
- SIFT 0.00
- ClinVar: Pathogenic/Likely pathogenic (Early-infantile DEE; Severe myoclonic epilepsy in infancy; See c)
- EBI: Pathogenic (in DRVT)
- UniProt: Pathogenic (in DRVT)
- Population evidence available
- Structural context available
- Cited in: Familial occurrence of febrile seizures and epilepsy in severe myoclonic epilepsy of infancy (SMEI) patients with SCN1A… (PMID 17054684)
- Cited in: De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. (PMID 11359211)